Rached Al Atassi, Wing Shun Chan, Zivile Jurjonaite, Rahel Kahsay, Emily Samson, Matthew D Jones
{"title":"Validity and reliability of a method to estimate the potential harm of medication errors by considering both the likelihood and degree of harm.","authors":"Rached Al Atassi, Wing Shun Chan, Zivile Jurjonaite, Rahel Kahsay, Emily Samson, Matthew D Jones","doi":"10.1093/ijpp/riae074","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>To develop a tool to 'risk score' the potential harm of a medication error by estimating the probability of a range of potential consequences, and assess its feasibility, validity, and reliability.</p><p><strong>Methods: </strong>The risk score tool described five levels of potential harm developed from an existing risk matrix. Judges estimated the likelihood of harm matching each level, from which a risk score (0-10) was calculated. Thirty judges (doctors, nurses, and pharmacists) used this risk score and the existing Dean and Barber scale to estimate the potential harm of 50 medication errors, 15 with a known outcome. Two weeks later, the judges re-scored ten of the errors. Reliability was investigated using generalizability theory.</p><p><strong>Key findings: </strong>Fifty medication errors were judged in a mean of 49 minutes with ≤0.7% missing data. There were no significant differences in the judges' rating of the realism and ease of use of the two tools. Fifty-nine per cent of judges preferred the risk score tool. For both tools, there was a clear relationship between mean score and known outcomes, with no overlap between outcome categories, confirming discriminative validity. The correlation between scores from both tools (R2 = 0.99) confirmed the concurrent criterion validity of the risk score. For both tools, at least three judges would need to score an error to obtain a generalizability coefficient of ≥0.8 using the mean score as an indicator of potential harm.</p><p><strong>Conclusions: </strong>The risk score was feasible, valid, and reliable. Its performance was comparable with, but did not exceed, the Dean and Barber scale.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":""},"PeriodicalIF":1.5000,"publicationDate":"2024-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Pharmacy Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/ijpp/riae074","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: To develop a tool to 'risk score' the potential harm of a medication error by estimating the probability of a range of potential consequences, and assess its feasibility, validity, and reliability.
Methods: The risk score tool described five levels of potential harm developed from an existing risk matrix. Judges estimated the likelihood of harm matching each level, from which a risk score (0-10) was calculated. Thirty judges (doctors, nurses, and pharmacists) used this risk score and the existing Dean and Barber scale to estimate the potential harm of 50 medication errors, 15 with a known outcome. Two weeks later, the judges re-scored ten of the errors. Reliability was investigated using generalizability theory.
Key findings: Fifty medication errors were judged in a mean of 49 minutes with ≤0.7% missing data. There were no significant differences in the judges' rating of the realism and ease of use of the two tools. Fifty-nine per cent of judges preferred the risk score tool. For both tools, there was a clear relationship between mean score and known outcomes, with no overlap between outcome categories, confirming discriminative validity. The correlation between scores from both tools (R2 = 0.99) confirmed the concurrent criterion validity of the risk score. For both tools, at least three judges would need to score an error to obtain a generalizability coefficient of ≥0.8 using the mean score as an indicator of potential harm.
Conclusions: The risk score was feasible, valid, and reliable. Its performance was comparable with, but did not exceed, the Dean and Barber scale.
目的:开发一种工具,通过估计一系列潜在后果的概率,对用药错误的潜在危害进行“风险评分”,并评估其可行性、有效性和可靠性。方法:风险评分工具描述了从现有风险矩阵开发的五个级别的潜在危害。评委们估计出与每个级别相匹配的危害可能性,并从中计算出风险评分(0-10)。30名法官(医生、护士和药剂师)使用这个风险评分和现有的Dean and Barber量表来估计50种药物错误的潜在危害,其中15种已知结果。两周后,裁判对其中的10个失误重新打分。采用概化理论对可靠性进行了研究。主要发现:平均49分钟内判断出50例用药错误,数据缺失率≤0.7%。评委对这两种工具的现实性和易用性的评价没有显著差异。59%的法官更喜欢风险评分工具。对于这两种工具,平均得分和已知结果之间存在明确的关系,结果类别之间没有重叠,确认了判别效度。两种工具的评分之间的相关性(R2 = 0.99)证实了风险评分的并发标准效度。对于这两种工具,至少需要三名法官对一个错误进行评分,以获得≥0.8的泛化系数,使用平均评分作为潜在危害的指标。结论:风险评分方法可行、有效、可靠。它的表现与迪恩和巴伯的规模相当,但没有超过。
期刊介绍:
The International Journal of Pharmacy Practice (IJPP) is a Medline-indexed, peer reviewed, international journal. It is one of the leading journals publishing health services research in the context of pharmacy, pharmaceutical care, medicines and medicines management. Regular sections in the journal include, editorials, literature reviews, original research, personal opinion and short communications. Topics covered include: medicines utilisation, medicine management, medicines distribution, supply and administration, pharmaceutical services, professional and patient/lay perspectives, public health (including, e.g. health promotion, needs assessment, health protection) evidence based practice, pharmacy education. Methods include both evaluative and exploratory work including, randomised controlled trials, surveys, epidemiological approaches, case studies, observational studies, and qualitative methods such as interviews and focus groups. Application of methods drawn from other disciplines e.g. psychology, health economics, morbidity are especially welcome as are developments of new methodologies.